ERBB2 and breast carcinoma: It was clarified that MDA-MB-231 was a breast cancer cell with low expressions of ER, PR and Her-2, while MDA-MD-435 was a breast cancer cell with low expressions of ER and PR but high expressions of Her-2 (Supplementary Figure 1).